LynkSolutec, which developed nano-coating technology for medical devices, completed the CES 2024 exhibition, the world’s largest consumer electronics and IT exhibition held in Las Vegas from the 9th to the 12th.

At CES 2024, LynkSolutec announced the launch of its disposable endoscopic cap “C.E.V.” with nano-coating technology. Under the slogan “Medical Side Effects? Not in Our World,” the demonstration was conducted using 3D video and actual endoscopes. In this process, famous endoscopy companies and many medical device manufacturers wooed Lynksolutec.

In addition to operating the booth, Seo Jungmok, a CEO at LynkSolutec, attended a meeting with Seoul Mayor Oh Se-hoon as the representative of a company and talked about regulating start-ups and improving the system. Seo also held an event to introduce his company’s core technology and C.E.V., an innovation award-winning product, at the main stage of the Seoul Pavilion and the Taiwan Pavilion.

“We made many achievements through CES 2024,” said Seo, CEO of LynkSolutec. “In addition to successfully introducing our first product to overseas markets, we have secured a network that will serve as a bridgehead to advance into overseas markets,” he said. “Based on this, we plan to rapidly expand our influence to the global market.”

Meanwhile, C.E.V. is a new medical device that can block even blood, mucus, and bacteria that cannot be blocked by anti-fog agents used in existing endoscopic surgery. It won two awards at the CES 2024 Innovation Awards.